Cvirn Gerhard, Gallistl Siegfried, Koestenberger Martin, Kutschera Joerg, Leschnik Bettina, Muntean Wolfgang
Ludwig Boltzmann Research Institute for Pediatric Hemostasis and Thrombosis, Graz, Austria.
Thromb Res. 2002 Mar 1;105(5):433-9. doi: 10.1016/s0049-3848(02)00042-7.
Protein S (PS) is a vitamin K-dependent plasma protein and serves as a cofactor for the anticoagulant activities of activated protein C (APC). We investigated the effects of different PS concentrations on prothrombin activation and thrombin generation in cord and adult plasma containing APC and different amounts of alpha 2-macroglobulin (a2-M). Prothrombin activation was assessed by monitoring the time-course of prothrombin fragment 1+2 (F1+2) generation. Thrombin generation curves were determined by means of a subsampling technique using the chromogenic substrate S-2238. We demonstrate a dose-dependent inhibition of the anticoagulant action of PS by a2-M: suppression of F1+2 and thrombin generation due to addition of PS was stronger in plasma containing low amounts of a2-M than in plasma with elevated a2-M levels. Since no complex formation between a2-M and PS was observed by means of SDS-PAGE, we attribute decreased anticoagulant action of PS at high a2-M levels to enhanced complex formation between APC and a2-M. Thereby, APC is subtracted from its cofactor PS, resulting in suppressed formation of the anticoagulant APC/PS complex. Thus, our data suggest that a2-M, besides its well-known anticoagulant effects, also acts as a procoagulant by suppressing the formation of the anticoagulant APC/PS complex. Our findings have implications particularly on thrombin generation and inhibition in cord plasma, since a2-M levels in newborns are elevated over adult values and the antithrombotic APC/PS pathway is up-regulated at birth. Therefore, elevated levels of a2-M might restrict the up-regulation of the APC/PS pathway.
蛋白 S(PS)是一种维生素 K 依赖的血浆蛋白,作为活化蛋白 C(APC)抗凝活性的辅因子。我们研究了不同浓度的 PS 对含有 APC 和不同量α2-巨球蛋白(α2-M)的脐带血和成人血浆中凝血酶原激活和凝血酶生成的影响。通过监测凝血酶原片段 1+2(F1+2)生成的时间进程来评估凝血酶原激活。使用发色底物 S-2238 通过亚取样技术确定凝血酶生成曲线。我们证明α2-M 对 PS 的抗凝作用有剂量依赖性抑制:在含有少量α2-M 的血浆中,由于添加 PS 导致的 F1+2 和凝血酶生成的抑制比在α2-M 水平升高的血浆中更强。由于通过 SDS-PAGE 未观察到α2-M 与 PS 之间形成复合物,我们将高α2-M 水平下 PS 抗凝作用的降低归因于 APC 与α2-M 之间复合物形成的增强。由此,APC 与其辅因子 PS 分离,导致抗凝性 APC/PS 复合物的形成受到抑制。因此,我们的数据表明,α2-M 除了其众所周知的抗凝作用外,还通过抑制抗凝性 APC/PS 复合物的形成而起到促凝作用。我们的发现对脐带血血浆中的凝血酶生成和抑制具有特别的意义,因为新生儿的α2-M 水平高于成人,并且抗血栓形成的 APC/PS 途径在出生时上调。因此,α2-M 水平升高可能会限制 APC/PS 途径的上调。